psychedelics stocks 2021

Debt is good, sometimes Debt is an important factor when sussing out a company to invest in. Knowing why the company has taken out debt, how much debt they’ve…
Data protection Earlier this week a federal review echoed The Canadian Ministry of Health’s original decision to deny data protection for Johnson & Johnson (JNJ.Q)’s Spravato product, a ketamine-derived…
Magnifying the problem   When lockdowns first hit back in March 2020 I was pretty sure the capital markets and the psychedelic sector would suffer. It was a burgeoning…
The strongest vertical? Ketamine One Capital (MEDI.NE), a company name that probably would have turned heads only 1 or 2 years ago, but now makes total sense is on…
+326% wtf? PharmaTher (PHRM.C), the Vancouver-based psychedelics company is on an impressive run. In the last month, the stock has rocketed from $0.19 CAD up to $0.81 CAD, a…
“The cardinal rule is to keep them playing and to keep them coming back. The longer they play, the more they lose, and in the end, we get it…
Speed Before the widespread fear-mongering in Western media and culture around LSD it was becoming rather popular in the psychiatry community in both North America and Europe. In the…
Esketamine Braxia Scientific (BRAX.C), formerly known as Champignon Brands had a rough 2020. It was a down year for many of us, but Champignon really found itself in trouble…
Nova Mentis (NOVA.C) is on a mission to incorporate psychedelics in treating chronic inflammatory conditions like autism spectrum disorder (ASD), fragile X syndrome (FXS), epilepsy, traumatic brain injury, multiple…
“I think drugs should be sold openly because it is an individual’s right to commit suicide if he wants to.” – Ayn Rand Weird timelines The Miami Heat made the…